What’s in Genetic Technologies Ltd – American Depositary Sha (NASDAQ:GENE) After Rise in Shorted Shares?

April 6, 2018 - By Winifred Garcia

The stock of Genetic Technologies Ltd – American Depositary Sha (NASDAQ:GENE) registered an increase of 14.15% in short interest. GENE’s total short interest was 1.04M shares in April as published by FINRA. Its up 14.15% from 907,400 shares, reported previously. With 442,300 shares average volume, it will take short sellers 2 days to cover their GENE’s short positions. The short interest to Genetic Technologies Ltd – American Depositary Sha’s float is 8.22%.

The stock increased 0.89% or $0.01 during the last trading session, reaching $1.13. About 5,775 shares traded. Genetic Technologies Limited (NASDAQ:GENE) has 0.00% since April 6, 2017 and is . It has underperformed by 11.55% the S&P500.

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the womenÂ’s health. The company has market cap of $18.95 million. The companyÂ’s lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It currently has negative earnings. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons primarily in Australia and the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.